U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from GEO Profiles

Items: 1 to 20 of 114

1.
mTOR activation induces endolysosomal remodeling and nonclassical secretion of IL-32 via exosomes in inflammatory reactive astrocytes
Kun Leng, Brendan Rooney, Frank McCarthy, Wenlong Xia, Indigo V. L. Rose, Sophie Bax, Marcus Chin, Saeed Fathi, Kari A. Herrington, Manuel Leonetti, Aimee Kao, Stephen P. J. Fancy, Joshua E. Elias, Martin Kampmann
J Neuroinflammation. 2024; 21: 198. Published online 2024 Aug 8. doi: 10.1186/s12974-024-03165-w
PMCID:
PMC11312292
AbstractArticlePDF–6.0M
2.
Rheumatoid Arthritis and Interleukin-32
H. Shoda, K. Fujio, K. Yamamoto
Cell Mol Life Sci. 2007 Oct; 64(19-20): 2671. Published online 2007 Jul 9. doi: 10.1007/s00018-007-7186-8
PMCID:
PMC11136180
AbstractArticlePDF–605K
3.
IL-32 Drives the Differentiation of Cardiotropic CD4+ T Cells Carrying HIV DNA in People With HIV
Hardik Ramani, Annie Gosselin, Rémi Bunet, Mohammad-Ali Jenabian, Mohamed Sylla, Amélie Pagliuzza, Carl Chartrand-Lefebvre, Jean-Pierre Routy, Jean-Philippe Goulet, Réjean Thomas, Benoit Trottier, Valérie Martel-Laferrière, Claude Fortin, Nicolas Chomont, Rémi Fromentin, Alan L Landay, Madeleine Durand, Petronela Ancuta, Mohamed El-Far, Cecile Tremblay
J Infect Dis. 2024 May 15; 229(5): 1277–1289. Published online 2023 Dec 19. doi: 10.1093/infdis/jiad576
PMCID:
PMC11095560
AbstractArticlePDF–1.3M
4.
IL32 downregulation lowers triglycerides and type I collagen in di-lineage human primary liver organoids
Kavitha Sasidharan, Andrea Caddeo, Oveis Jamialahmadi, Francesca Rita Noto, Melissa Tomasi, Francesco Malvestiti, Ester Ciociola, Federica Tavaglione, Rosellina M. Mancina, Alessandro Cherubini, Cristiana Bianco, Angela Mirarchi, Ville Männistö, Jussi Pihlajamäki, Vesa Kärjä, Stefania Grimaudo, Panu K. Luukkonen, Sami Qadri, Hannele Yki-Järvinen, Salvatore Petta, Silvia Manfrini, Umberto Vespasiani-Gentilucci, Vincenzo Bruni, Luca Valenti, Stefano Romeo
Cell Rep Med. 2024 Jan 16; 5(1): 101352. Published online 2024 Jan 16. doi: 10.1016/j.xcrm.2023.101352
PMCID:
PMC10829727
AbstractArticlePDF–4.7M
5.
Saturated Fat-Mediated Upregulation of IL-32 and CCL20 in Hepatocytes Contributes to Higher Expression of These Fibrosis-Driving Molecules in MASLD
Katharina Schilcher, Rania Dayoub, Marion Kubitza, Jakob Riepl, Kathrin Klein, Christa Buechler, Michael Melter, Thomas S. Weiss
Int J Mol Sci. 2023 Sep; 24(17): 13222. Published online 2023 Aug 25. doi: 10.3390/ijms241713222
PMCID:
PMC10487578
AbstractArticlePDF–1.2M
6.
Estimation of Interleukin 32 and Interleukin 37 Serum Levels in Iraqi Patients with Rheumatoid Arthritis
Mohammed Jasim E, Khudhur Jameel S, Ihsan Awadh N
Arch Razi Inst. 2023 Apr; 78(2): 743–750. Published online 2023 Apr 30. doi: 10.22092/ARI.2022.359861.2489
PMCID:
PMC10314259
AbstractArticlePDF–493K
7.
Human IL-32θA94V mutant attenuates monocyte-endothelial adhesion by suppressing the expression of ICAM-1 and VCAM-1 via binding to cell surface receptor integrin αVβ3 and αVβ6 in TNF-α-stimulated HUVECs
Jae-Young Park, Hyo-Min Park, Seonhwa Kim, Kyeong-Bae Jeon, Chae-Min Lim, Jin Tae Hong, Do-Young Yoon
Front Immunol. 2023; 14: 1160301. Published online 2023 May 9. doi: 10.3389/fimmu.2023.1160301
PMCID:
PMC10203490
AbstractArticlePDF–6.5M
8.
Differential Impact of IL-32 Isoforms on the Functions of Coronary Artery Endothelial Cells: A Potential Link with Arterial Stiffness and Atherosclerosis
Rémi Bunet, Marie-Hélène Roy-Cardinal, Hardik Ramani, Aurélie Cleret-Buhot, Madeleine Durand, Carl Chartrand-Lefebvre, Jean-Pierre Routy, Réjean Thomas, Benoît Trottier, Petronela Ancuta, David B. Hanna, Alan L. Landay, Guy Cloutier, Cécile L. Tremblay, Mohamed El-Far
Viruses. 2023 Mar; 15(3): 700. Published online 2023 Mar 8. doi: 10.3390/v15030700
PMCID:
PMC10052544
AbstractArticlePDF–15M
9.
Predicting roles of IL-27 and IL-32 in determining the severity and outcome of COVID-19
Batool Zamani, Maedeh Najafizadeh, Hossein Motedayyen, Reza Arefnezhad
Int J Immunopathol Pharmacol. 2022 Jan-Dec; 36: 03946320221145827. Published online 2022 Dec 8. doi: 10.1177/03946320221145827
PMCID:
PMC9742516
AbstractArticlePDF–931K
10.
Genetic Association between Polymorphisms of Interleukin-32 and Dilated Cardiomyopathy in Chinese Han Population
Ying Peng, Xuemei Zhong, Yanyun Wang, Bin Zhou, Yaping Song, Min Su, Zhilong Li, Qin Li, Li Rao
Dis Markers. 2022; 2022: 5946290. Published online 2022 Dec 2. doi: 10.1155/2022/5946290
PMCID:
PMC9733993
AbstractArticlePDF–242K
11.
Interleukin 32 as a Potential Marker for Diagnosis of Tuberculous Pleural Effusion
Juan Du, Ming-Ming Shao, Feng-Shuang Yi, Zhong-Yin Huang, Xin Qiao, Qing-Yu Chen, Huan-Zhong Shi, Kan Zhai
Microbiol Spectr. 2022 Jul-Aug; 10(4): e02553-21. Published online 2022 Jul 26. doi: 10.1128/spectrum.02553-21
PMCID:
PMC9430160
AbstractArticlePDF–705K
12.
Natural Killer Cell Transcript 4 promotes the development of Sjögren’s Syndrome via activation of Rap1 on B cells
Peng Qu, Todd Wuest, Yongfen Min, Ilias Alevizos, Howard A. Young, P. Charles Lin
J Autoimmun. Author manuscript; available in PMC 2022 Jul 8.
Published in final edited form as: J Autoimmun. 2021 Jan; 116: 102559. Published online 2020 Oct 19. doi: 10.1016/j.jaut.2020.102559
PMCID:
PMC9264267
AbstractArticlePDF–2.2M
13.
IL-32 promotes the occurrence of atopic dermatitis by activating the JAK1/microRNA-155 axis
Jing Chang, Bin Zhou, Zhu Wei, Yongqi Luo
J Transl Med. 2022; 20: 207. Published online 2022 May 11. doi: 10.1186/s12967-022-03375-x
PMCID:
PMC9097387
AbstractArticlePDF–1.9M
14.
Extracellular vesicle IL-32 promotes the M2 macrophage polarization and metastasis of esophageal squamous cell carcinoma via FAK/STAT3 pathway
Yixuan Sun, Yuzhen Qian, Chunxia Chen, Hongfei Wang, Xiuman Zhou, Wenjie Zhai, Lu Qiu, Xiaowen Zhou, Haoming Ning, Yumiao Zhao, Chao Shi, Lu Han, Yuanming Qi, Yahong Wu, Yanfeng Gao
J Exp Clin Cancer Res. 2022; 41: 145. Published online 2022 Apr 15. doi: 10.1186/s13046-022-02348-8
PMCID:
PMC9013041
AbstractArticlePDF–12M
15.
Myeloma-derived IL-32γ induced PD-L1 expression in macrophages facilitates immune escape via the PFKFB3-JAK1 axis
Yang Liu, Haimeng Yan, Huiyao Gu, Enfan Zhang, Jingsong He, Wen Cao, Jianwei Qu, Ruyi Xu, Liqin Cao, Donghua He, Jinna Zhang, Yifan Hou, Zhen Cai
Oncoimmunology. 2022; 11(1): 2057837. Published online 2022 Mar 31. doi: 10.1080/2162402X.2022.2057837
PMCID:
PMC8973380
AbstractArticlePDF–6.8M
16.
A Paradoxical Effect of Interleukin-32 Isoforms on Cancer
Saerok Shim, Siyoung Lee, Yasmin Hisham, Sinae Kim, Tam T. Nguyen, Afeisha S. Taitt, Jihyeong Hwang, Hyunjhung Jhun, Ho-Young Park, Youngmin Lee, Su Cheong Yeom, Sang-Yeob Kim, Yong-Gil Kim, Soohyun Kim
Front Immunol. 2022; 13: 837590. Published online 2022 Feb 25. doi: 10.3389/fimmu.2022.837590
PMCID:
PMC8913503
AbstractArticlePDF–2.9M
17.
Identification of molecular subtyping system and four-gene prognostic signature with immune-related genes for uveal melanoma
Fei Xia, Zhilong Yu, Aijun Deng, Guohong Gao
Exp Biol Med (Maywood) 2022 Feb; 247(3): 246–262. Published online 2021 Nov 7. doi: 10.1177/15353702211053801
PMCID:
PMC8851532
AbstractArticlePDF–3.9M
18.
Interleukin-32γ in the Control of Acute Experimental Chagas Disease
Yarlla L. L. Braga, José R. C. Neto, Arthur W. F. Costa, Muriel V. T. Silva, Marcos V. Silva, Mara R. N. Celes, Milton A. P. Oliveira, Leo A. B. Joosten, Fátima Ribeiro-Dias, Rodrigo S. Gomes, Juliana R. Machado
J Immunol Res. 2022; 2022: 7070301. Published online 2022 Jan 20. doi: 10.1155/2022/7070301
PMCID:
PMC8794684
AbstractArticlePDF–1.0M
19.
Effects of IL‐32 polymorphisms and IL‐32 levels on the susceptibility and severity of coronary artery disease
Susu Jin, Xiujing Liu, Yingying Wang, Jian Yu, Minghua Jiang
J Clin Lab Anal. 2022 Jan; 36(1): e24114. Published online 2021 Nov 19. doi: 10.1002/jcla.24114
PMCID:
PMC8761453
AbstractArticlePDF–540K
20.
Subclinical carotid artery atherosclerosis is associated with increased expression of peripheral blood IL-32 isoforms among women living with HIV
Mohamed El-Far, David B. Hanna, Madeleine Durand, Etienne Larouche-Anctil, Mohamed Sylla, Carl Chartrand-Lefebvre, Guy Cloutier, Jean Philippe Goulet, Seble Kassaye, Roksana Karim, Jorge R. Kizer, Audrey L. French, Stephen J. Gange, Jason M. Lazar, Howard N. Hodis, Jean-Pierre Routy, Petronela Ancuta, Nicolas Chomont, Alan L. Landay, Robert C. Kaplan, Cécile L. Tremblay
J Acquir Immune Defic Syndr. Author manuscript; available in PMC 2022 Oct 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2021 Oct 1; 88(2): 186–191. doi: 10.1097/QAI.0000000000002746
PMCID:
PMC8434945
AbstractArticlePDF–775K

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

You are here: NCBI > Literature > PubMed Central (PMC)
Support Center